Mark T. Iwicki - Insider Trading & Ownership

Entity
Individual
Location
84 Waterford Drive, Marlborough, MA
Summary
The estimated net worth of Mark T. Iwicki is at least $1.92M dollars as of June 27, 2024. Mark T. Iwicki is the CHIEF EXECUTIVE OFFICER, Director of KALA BIO, Inc. and owns shares of KALA BIO, Inc. (KALA) stock worth about $1.25M. Mark T. Iwicki is the Director of Homology Medicines, Inc. and owns shares of Q32 Bio Inc. (QTTB) stock worth about $343K. Mark T. Iwicki is the Director of Aerovate Therapeutics, Inc. and owns shares of Aerovate Therapeutics, Inc. (AVTE) stock worth about $205K. Mark T. Iwicki is the Director of Merus N.V. and owns shares of Merus N.V. (MRUS) stock worth about $120K.
All Insider Reports
All Insider Reports

Ownership of Mark T. Iwicki

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
KALA KALA BIO, Inc. CHIEF EXECUTIVE OFFICER, Director $1.25M -$148K -10.5% Jun 26, 2024
QTTB Q32 Bio Inc. Director $343K Mar 25, 2024
AVTE Aerovate Therapeutics, Inc. Director $205K Jun 5, 2024
MRUS Merus N.V. Director $120K May 7, 2024
AKRO Akero Therapeutics, Inc. Director Jun 8, 2024
THRD Third Harmonic Bio, Inc. Director Jun 6, 2024

Insider Transactions Reported by Mark T. Iwicki:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.